{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:25Z","timestamp":1781636065621,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rosacea episcleritis, scleritis and uveitis may be missed when clinicians focus on the eye without appraising the adnexae and facial skin. Addressing rosacea can reduce treatment failures and avoid systemic complications of less effective or more toxic drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case series and narrative review<\/jats:title>\n                    <jats:p>This series presents four cases with scleritis and \/ or sclero-uveitis in the setting of facial or ocular rosacea. Where relevant, negative systemic scleritis work up is included. Common features were incomplete resolution or poor response to one or more of topical and systemic steroid, systemic non-steroidal anti-inflammatory, systemic immunomodulatory and topical antibiotic treatment. All cases responded promptly to treatment with oral doxycycline, allowing withdrawal of other treatment. A review of the literature is presented, updating understanding of immunogenetics and inflammatory pathways relevant to ophthalmic management of these cases. Important considerations include the role of steroids, vitamin D, microbes, toll like receptors and their influence on the cathelicidin (Ll-17) pathway in rosacea inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Making a correct rosacea diagnosis and managing with doxycycline or related medication can result in rapid remission, minimising disease complications and side effects of less targeted drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-025-00546-x","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:24:43Z","timestamp":1770917083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rosacea scleritis and sclero-uveitis; under recognised and over treated"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8914-3478","authenticated-orcid":false,"given":"Josephine","family":"Richards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"2","key":"546_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.det.2017.11.001","volume":"36","author":"CS Ahn","year":"2018","unstructured":"Ahn CS, Huang WW (2018) Rosacea pathogenesis. Dermatol Clin 36(2):81\u201386","journal-title":"Dermatol Clin"},{"key":"546_CR2","doi-asserted-by":"crossref","unstructured":"Alexis AF, Callender VD, Baldwin HE, Desai SR, Rendon MI, Taylor SC (2019) Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and clinical practice experience. J Am Acad Dermatol 80(6):1722-9.e7","DOI":"10.1016\/j.jaad.2018.08.049"},{"issue":"1","key":"546_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0002-9394(03)00890-0","volume":"137","author":"SA Nazir","year":"2004","unstructured":"Nazir SA, Murphy S, Siatkowski RM, Chodosh J, Siatkowski RL (2004) Ocular rosacea in childhood. Am J Ophthalmol 137(1):138\u2013144","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"546_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/09273948.2019.1668951","volume":"29","author":"O Donmez","year":"2021","unstructured":"Donmez O, Akova YA (2021) Pediatric ocular acne rosacea: clinical features and long term Follow-Up of sixteen cases. Ocul Immunol Inflamm 29(1):57\u201365","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"546_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","volume":"119","author":"M de la Sainz","year":"2012","unstructured":"de la Sainz M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS (2012) Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology 119(1):43\u201350","journal-title":"Ophthalmology"},{"issue":"4","key":"546_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","volume":"130","author":"DA Jabs","year":"2000","unstructured":"Jabs DA, Mudun A, Dunn JP, Marsh MJ (2000) Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 130(4):469\u2013476","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"546_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/ceo.13761","volume":"48","author":"LP Thong","year":"2020","unstructured":"Thong LP, Rogers SL, Hart CT, Hall AJ, Lim LL (2020) Epidemiology of episcleritis and scleritis in urban Australia. Clin Exp Ophthalmol 48(6):757\u2013766","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"546_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1442-9071.1991.tb00663.x","volume":"19","author":"P McCluskey","year":"1991","unstructured":"McCluskey P, Wakefield D (1991) Prediction of response to treatment in patients with scleritis using a standardised scoring system. Aust N Z J Ophthalmol 19(3):211\u2013215","journal-title":"Aust N Z J Ophthalmol"},{"issue":"2","key":"546_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/ceo.13900","volume":"49","author":"S Tavassoli","year":"2021","unstructured":"Tavassoli S, Wong N, Chan E (2021) Ocular manifestations of rosacea: A clinical review. Clin Exp Ophthalmol 49(2):104\u2013117","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"546_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1172\/JCI30142","volume":"117","author":"J Schauber","year":"2007","unstructured":"Schauber J, Dorschner RA, Coda AB, B\u00fcchau AS, Liu PT, Kiken D et al (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117(3):803\u2013811","journal-title":"J Clin Invest"},{"issue":"10","key":"546_CR11","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0161-6420(00)00347-X","volume":"107","author":"PJ Pisella","year":"2000","unstructured":"Pisella PJ, Brignole F, Debbasch C, Lozato PA, Creuzot-Garcher C, Bara J et al (2000) Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis Sicca. Ophthalmology 107(10):1841\u20131849","journal-title":"Ophthalmology"},{"issue":"4","key":"546_CR12","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jaad.2017.09.016","volume":"78","author":"R Haber","year":"2018","unstructured":"Haber R, El Gemayel M (2018) Comorbidities in rosacea: A systematic review and update. J Am Acad Dermatol 78(4):786\u201392e8","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"546_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaad.2015.07.009","volume":"73","author":"BM Rainer","year":"2015","unstructured":"Rainer BM, Fischer AH, Luz Felipe da Silva D, Kang S, Chien AL (2015) Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J Am Acad Dermatol 73(4):604\u2013608","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"546_CR14","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1136\/bjophthalmol-2017-310975","volume":"102","author":"CY Lee","year":"2018","unstructured":"Lee CY, Chen HC, Lin HW, Huang JY, Chao SC, Yeh CB et al (2018) Blepharitis as an early sign of metabolic syndrome: a nationwide population-based study. Br J Ophthalmol 102(9):1283\u20131287","journal-title":"Br J Ophthalmol"},{"key":"546_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.yjmcc.2019.12.011","volume":"139","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhang Y, Zhang J, Zhai T, Hu J, Luo H et al (2020) Cathelicidin aggravates myocardial ischemia\/reperfusion injury via activating TLR4 signaling and P2X(7)R\/NLRP3 inflammasome. J Mol Cell Cardiol 139:75\u201386","journal-title":"J Mol Cell Cardiol"},{"key":"546_CR16","doi-asserted-by":"crossref","unstructured":"Ahmed A, Siman-Tov G, Hall G, Bhalla N, Narayanan A (2019) Human antimicrobial peptides as therapeutics for viral infections. Viruses 11(8)","DOI":"10.3390\/v11080704"},{"issue":"1","key":"546_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/jidsymp.2011.4","volume":"15","author":"K Yamasaki","year":"2011","unstructured":"Yamasaki K GR (2011) Rosacea as a disease of cathelicidins and skin innate immunity. J Investig Dermatol Symp Proc 15(1):12\u201315","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"11","key":"546_CR18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1172\/JCI17545","volume":"111","author":"R Koczulla","year":"2003","unstructured":"Koczulla R, von Degenfeld G, Kupatt C, Kr\u00f6tz F, Zahler S, Gloe T et al (2003) An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18. J Clin Invest 111(11):1665\u20131672","journal-title":"J Clin Invest"},{"issue":"2","key":"546_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5021\/ad.2018.30.2.136","volume":"30","author":"BW Park","year":"2018","unstructured":"Park BW, Ha JM, Cho EB, Jin JK, Park EJ, Park HR et al (2018) A study on vitamin D and Cathelicidin status in patients with rosacea: serum level and tissue expression. Ann Dermatol 30(2):136\u2013142","journal-title":"Ann Dermatol"},{"issue":"8","key":"546_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm1616","volume":"13","author":"K Yamasaki","year":"2007","unstructured":"Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A et al (2007) Increased Serine protease activity and Cathelicidin promotes skin inflammation in rosacea. Nat Med 13(8):975\u2013980","journal-title":"Nat Med"},{"issue":"7","key":"546_CR21","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1080\/09273948.2018.1504971","volume":"27","author":"NB Gokcinar","year":"2019","unstructured":"Gokcinar NB, Karabulut AA, Onaran Z, Yumusak E, Budak Yildiran FA (2019) Elevated tear human neutrophil peptides 1\u20133, human beta Defensin-2 levels and conjunctival Cathelicidin LL-37 gene expression in ocular rosacea. Ocul Immunol Inflamm 27(7):1174\u20131183","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"546_CR22","first-page":"2506","volume":"40","author":"AA Afonso","year":"1999","unstructured":"Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC (1999) Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 40(11):2506\u20132512","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"546_CR23","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/S0161-6420(97)30014-1","volume":"104","author":"K Barton","year":"1997","unstructured":"Barton K, Monroy DC, Nava A, Pflugfelder SC (1997) Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology 104(11):1868\u20131874","journal-title":"Ophthalmology"},{"issue":"3","key":"546_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/jid.2010.351","volume":"131","author":"K Yamasaki","year":"2011","unstructured":"Yamasaki K, Kanada K, Macleod DT, Borkowski AW, Morizane S, Nakatsuji T et al (2011) TLR2 expression is increased in rosacea and stimulates enhanced Serine protease production by keratinocytes. J Invest Dermatol 131(3):688\u2013697","journal-title":"J Invest Dermatol"},{"issue":"9","key":"546_CR25","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1096\/fj.04-3284com","volume":"19","author":"AF Gombart","year":"2005","unstructured":"Gombart AF, Borregaard N, Koeffler HP (2005) Human Cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. Faseb J 19(9):1067\u20131077","journal-title":"Faseb J"},{"issue":"5768","key":"546_CR26","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1126\/science.1123933","volume":"311","author":"PT Liu","year":"2006","unstructured":"Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768):1770\u20131773","journal-title":"Science"},{"issue":"1","key":"546_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/joim.13149","volume":"289","author":"JM Rhodes","year":"2021","unstructured":"Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA, Perspective (2021) Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis. J Intern Med 289(1):97\u2013115","journal-title":"J Intern Med"},{"issue":"2","key":"546_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/jid.2008.237","volume":"129","author":"M Shibata","year":"2009","unstructured":"Shibata M, Katsuyama M, Onodera T, Ehama R, Hosoi J, Tagami H (2009) Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or Proinflammatory cytokines. J Invest Dermatol 129(2):375\u2013382","journal-title":"J Invest Dermatol"},{"key":"546_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jsbmb.2017.03.023","volume":"171","author":"Q Su","year":"2017","unstructured":"Su Q, Pfalzgraff A, Weindl G (2017) Cell type-specific regulatory effects of glucocorticoids on cutaneous TLR2 expression and signalling. J Steroid Biochem Mol Biol 171:201\u2013208","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"546_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10875-008-9225-0","volume":"29","author":"M Wik\u00e9n","year":"2009","unstructured":"Wik\u00e9n M, Grunewald J, Eklund A, Wahlstr\u00f6m J (2009) Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol 29(1):78\u201389","journal-title":"J Clin Immunol"},{"issue":"4","key":"546_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1165\/rcmb.2004-0161OC","volume":"31","author":"T Homma","year":"2004","unstructured":"Homma T, Kato A, Hashimoto N, Batchelor J, Yoshikawa M, Imai S et al (2004) Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. Am J Respir Cell Mol Biol 31(4):463\u2013469","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"546_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/cei.12138","volume":"173","author":"MI Gabrilovich","year":"2013","unstructured":"Gabrilovich MI, Walrath J, van Lunteren J, Nethery D, Seifu M, Kern JA et al (2013) Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol 173(3):512\u2013522","journal-title":"Clin Exp Immunol"},{"key":"546_CR33","doi-asserted-by":"publisher","first-page":"1201575","DOI":"10.3389\/fimmu.2023.1201575","volume":"14","author":"RD Reitsema","year":"2023","unstructured":"Reitsema RD, Hesselink BC, Abdulahad WH, van der Geest KSM, Brouwer E, Heeringa P et al (2023) Aberrant phenotype of Circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica. Front Immunol 14:1201575","journal-title":"Front Immunol"},{"issue":"8","key":"546_CR34","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/ddg.14849","volume":"20","author":"BM Clanner-Engelshofen","year":"2022","unstructured":"Clanner-Engelshofen BM, Bernhard D, Dargatz S, Flaig MJ, Gieler U, Kinberger M et al (2022) S2k guideline: rosacea. J Dtsch Dermatol Ges 20(8):1147\u20131165","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"546_CR35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/jid.2012.14","volume":"132","author":"KN Kanada","year":"2012","unstructured":"Kanada KN, Nakatsuji T, Gallo RL (2012) Doxycycline indirectly inhibits proteolytic activation of tryptic kallikrein-related peptidases and activation of Cathelicidin. J Invest Dermatol 132(5):1435\u20131442","journal-title":"J Invest Dermatol"},{"issue":"4","key":"546_CR36","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1124\/mol.104.006346","volume":"67","author":"RA Garc\u00eda","year":"2005","unstructured":"Garc\u00eda RA, Pantazatos DP, Gessner CR, Go KV, Woods VL Jr., Villarreal FJ (2005) Molecular interactions between matrilysin and the matrix metalloproteinase inhibitor Doxycycline investigated by deuterium exchange mass spectrometry. Mol Pharmacol 67(4):1128\u20131136","journal-title":"Mol Pharmacol"},{"issue":"7","key":"546_CR37","first-page":"1703","volume":"41","author":"L Sobrin","year":"2000","unstructured":"Sobrin L, Liu Z, Monroy DC, Solomon A, Selzer MG, Lokeshwar BL et al (2000) Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci 41(7):1703\u20131709","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"546_CR38","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00417-005-0212-3","volume":"244","author":"M M\u00e4\u00e4tt\u00e4","year":"2006","unstructured":"M\u00e4\u00e4tt\u00e4 M, Kari O, Tervahartiala T, Peltonen S, Kari M, Saari M et al (2006) Tear fluid levels of MMP-8 are elevated in ocular rosacea\u2013treatment effect of oral Doxycycline. Graefes Arch Clin Exp Ophthalmol 244(8):957\u2013962","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"546_CR39","first-page":"14","volume":"14","author":"JQ Del Rosso","year":"2021","unstructured":"Del Rosso JQ, Webster G, Weiss JS, Bhatia ND, Gold LS, Kircik L (2021) Nonantibiotic properties of tetracyclines in rosacea and their clinical implications. J Clin Aesthet Dermatol 14(8):14\u201321","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"546_CR40","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41467-021-21533-5","volume":"12","author":"D Minns","year":"2021","unstructured":"Minns D, Smith KJ, Alessandrini V, Hardisty G, Melrose L, Jackson-Jones L et al (2021) The neutrophil antimicrobial peptide Cathelicidin promotes Th17 differentiation. Nat Commun 12(1):1285","journal-title":"Nat Commun"},{"issue":"2","key":"546_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/12034754241229365","volume":"28","author":"RSQ Geng","year":"2024","unstructured":"Geng RSQ, Bourkas AN, Mufti A, Sibbald RG (2024) Rosacea: pathogenesis and therapeutic correlates. J Cutan Med Surg 28(2):178\u2013189","journal-title":"J Cutan Med Surg"},{"issue":"Suppl 1","key":"546_CR42","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.3109\/09546634.2016.1145338","volume":"27","author":"J Leyden","year":"2016","unstructured":"Leyden J (2016) Recent advances in the use of adapalene 0.1%\/benzoyl peroxide 2.5% to treat patients with moderate to severe acne. J Dermatolog Treat 27(Suppl 1):S4\u201313","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"546_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s13555-017-0176-3","volume":"7","author":"S Thibaut de M\u00e9nonville","year":"2017","unstructured":"Thibaut de M\u00e9nonville S, Rosignoli C, Soares E, Roquet M, Bertino B, Chappuis JP et al (2017) Topical treatment of rosacea with Ivermectin inhibits gene expression of Cathelicidin innate immune Mediators, LL-37 and KLK5, in reconstructed and ex vivo skin models. Dermatol Ther (Heidelb) 7(2):213\u2013225","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"546_CR44","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ophtha.2019.06.030","volume":"127","author":"ZK Chiu","year":"2020","unstructured":"Chiu ZK, Lim LL, Rogers SL, Hall AJ (2020) Patterns of vitamin D levels and exposures in active and inactive noninfectious uveitis patients. Ophthalmology 127(2):230\u2013237","journal-title":"Ophthalmology"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-025-00546-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00546-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00546-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:11:41Z","timestamp":1781633501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-025-00546-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1186\/s12348-025-00546-x","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"1 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Received approval from the RPBG surgical division of the Governance, Ethics, Knowledge, Outcomes team (GEKO), including for publication. It is registered as quality activity 64572.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The four patients have consented to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}